These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19884815)

  • 1. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes.
    Saito T; Urushihara M; Kotani Y; Kagami S; Kobori H
    Am J Med Sci; 2009 Dec; 338(6):478-80. PubMed ID: 19884815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
    Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
    Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients.
    Zhuang Z; Bai Q; A L; Liang Y; Zheng D; Wang Y
    Int J Clin Exp Pathol; 2015; 8(9):11464-9. PubMed ID: 26617876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor activation with calcitriol for reducing urinary angiotensinogen in patients with type 2 diabetic chronic kidney disease.
    Tiryaki Ö; Usalan C; Sayiner ZA
    Ren Fail; 2016; 38(2):222-7. PubMed ID: 26707134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
    Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
    Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus.
    Ba Aqeel S; Ye M; Wysocki J; Sanchez A; Khattab A; Lores E; Rademaker A; Gao X; Bebu I; Nelson RG; Molitch M; Batlle D;
    Physiol Rep; 2019 Oct; 7(19):e14242. PubMed ID: 31605461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.
    Uzu T; Araki SI; Kashiwagi A; Haneda M; Koya D; Yokoyama H; Kida Y; Ikebuchi M; Nakamura T; Nishimura M; Takahara N; Obata T; Omichi N; Sakamoto K; Shingu R; Taki H; Nagai Y; Tokuda H; Kitada M; Misawa M; Nishiyama A; Kobori H; Maegawa H;
    PLoS One; 2016; 11(12):e0164936. PubMed ID: 28033332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes.
    Kamiyama M; Zsombok A; Kobori H
    J Pharmacol Sci; 2012; 119(4):314-23. PubMed ID: 22850612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A; Konishi Y; Ohashi N; Morikawa T; Urushihara M; Maeda I; Hamada M; Kishida M; Hitomi H; Shirahashi N; Kobori H; Imanishi M
    Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
    de Alencar Franco Costa D; Todiras M; Campos LA; Cipolla-Neto J; Bader M; Baltatu OC
    Acta Physiol (Oxf); 2015 Mar; 213(3):740-6. PubMed ID: 25529203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?
    Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O
    Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubular and glomerular injury in diabetes and the impact of ACE inhibition.
    Nielsen SE; Sugaya T; Tarnow L; Lajer M; Schjoedt KJ; Astrup AS; Baba T; Parving HH; Rossing P
    Diabetes Care; 2009 Sep; 32(9):1684-8. PubMed ID: 19502542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.
    Satirapoj B; Siritaweesuk N; Supasyndh O
    Clin Kidney J; 2014 Aug; 7(4):354-60. PubMed ID: 25852909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients.
    Nielsen SE; Sugaya T; Hovind P; Baba T; Parving HH; Rossing P
    Diabetes Care; 2010 Jun; 33(6):1320-4. PubMed ID: 20185732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
    J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
    Chiarelli F; Verrotti A; Mohn A; Morgese G
    Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.